Long Cannabis article in latest IC8 Sep 2018 15:10
‼️SUBSCRIPTION ONLY ...SO THIS EXTRACT IS WHAT I THOUGHT WAS RELEVANT....but no mention of doggy Lenigas AFRI .....lo‼️
In the UK, access to that potentially enormous market currently lies in the hands of just three companies. Ananda, Sativa Investments (Nex:SATI) and High Growth Capital (Nex:HASH) are all NEX-listed investment vehicles, set up to benefit from the surging demand for medicinal cannabis. With some of the £1m raised at its IPO, Sativa has taken a stake in two Canadian-based pharmaceutical cannabis companies, Veritas and Rapid Dose Therapeutics. Ananda has backed an Israeli company that is aiming to improve the process of extracting CBDs and THCs from cannabis. The group is looking to make further investments in the whole spectrum of cannabis applications: genetics, growing, lighting, bolt-on devices and services.
Both companies will no doubt hope to replicate the success of the UK’s first medicinal cannabis company, GW Pharmaceuticals (US:GWPH), which cancelled its Aim listed in 2017 in favour of the US Nasdaq market. GW was the first company to gain approval for a pharmaceutical grade medicine which uses both CBDs and THCs. Its two drugs, Sativex and Epidiolex, are used to treat multiple sclerosis and epilepsy, respectively, and are approved in the UK, Canada and much of Europe. The potential success of ongoing US trials could be another catalyst for the share price which is already up a tenth in 2018.
Outside of the UK, there are a number of opportunities for investors to grab a slice of the medicinal cannabis market. Cara Therapeutics (US:CARA) and Axim Biosciences (US:AXIM) both have drugs in the early stages of development that could be used for a range of illnesses, while pharma giant AbbVie (US:ABBV) has a synthetic cannabis-based treatment which is used to treat nausea associated with chemotherapy.
Meanwhile, there is a growing pool of cannabis companies that have expressed an interest in listing on the UK’s main or Aim market. Nick Davis, a lawyer at Memery Crystal, says his firm is currently talking to half a dozen companies which are considering IPO, that compares to zero this time last year: “London is just starting to wake up and catch up”. MB
🤣🍻
Sign In
Follow the stocks
